Robert B. Hance, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 79,728 shares at $54.28 ($4.3M) on 2011-12-14, disclosed to the SEC on 2011-12-16.
Scheduled sale ($4.3M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.28 | 1,700 | $92K | 2.1% |
| 2 | $54.29 | 7,000 | $380K | 8.8% |
| 3 | $54.29 | 19,866 | $1.1M | 24.9% |
| 4 | $54.29 | 300 | $16K | 0.4% |
| 5 | $54.29 | 1,000 | $54K | 1.3% |
| 6 | $54.30 | 4,900 |
| $266K |
| 6.1% |
| 7 | $54.30 | 800 | $43K | 1.0% |
| 8 | $54.31 | 5,173 | $281K | 6.5% |
| 9 | $54.32 | 3,100 | $168K | 3.9% |
| 10 | $54.32 | 500 | $27K | 0.6% |
| 11 | $54.32 | 7,327 | $398K | 9.2% |
| 12 | $54.32 | 17,900 | $972K | 22.5% |
| 13 | $54.33 | 2,119 | $115K | 2.7% |
| 14 | $54.34 | 4,800 | $261K | 6.0% |
| 15 | $54.34 | 200 | $11K | 0.3% |
| 16 | $54.34 | 800 | $43K | 1.0% |
| 17 | $54.35 | 100 | $5K | 0.1% |
| 18 | $54.35 | 200 | $11K | 0.3% |
| 19 | $54.36 | 100 | $5K | 0.1% |
| 20 | $54.23 | 1,843 | $100K | 2.3% |
| Total | $54.31 avg | 79,728 | $4.3M | 100% |
| Filing → |
| ABT | SELL | 2012-03-02 | $4.6M | — | Filing → |
| ABT | SELL | 2011-03-02 | $75K | — | Filing → |
| ABT | SELL | 2011-02-10 | $2.4M | — | Filing → |